The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer
- PMID: 31001266
- PMCID: PMC6454067
- DOI: 10.3389/fimmu.2019.00653
The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer
Abstract
Patients with human papilloma virus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) have remarkably better prognosis, which differs from HPV-negative oropharyngeal squamous cell carcinoma (OPSCC) with respect to clinical, genomic, molecular, and immunological aspects, especially having the characteristics of high levels of immune cell infiltration and high degrees of immunosuppression. This review will summarize immune evasion mechanisms in HPV-positive HNSCC, analyze the host various immune responses to HPV and abundant numbers of infiltrating immune cell, and discuss the differences between HPV-positive HNSCC with cervical cancer. A deeper understanding of the immune landscape will help new concepts to emerge in immune-checkpoint oncology, which might be a valuable add-on to established concepts.
Keywords: head and neck squamous cell carcinoma (HNSCC); human papilloma virus (HPV); immune escape; immune responses; immunotherapy.
Figures


Similar articles
-
The interplay between HPV and host immunity in head and neck squamous cell carcinoma.Int J Cancer. 2014 Jun 15;134(12):2755-63. doi: 10.1002/ijc.28411. Epub 2013 Aug 29. Int J Cancer. 2014. PMID: 23913554 Review.
-
Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.Front Immunol. 2019 Dec 3;10:2831. doi: 10.3389/fimmu.2019.02831. eCollection 2019. Front Immunol. 2019. PMID: 31849993 Free PMC article. Review.
-
Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.JAMA Otolaryngol Head Neck Surg. 2022 Jan 1;148(1):70-79. doi: 10.1001/jamaoto.2021.3228. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 34792560 Free PMC article.
-
Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.Cells. 2019 Sep 10;8(9):1061. doi: 10.3390/cells8091061. Cells. 2019. PMID: 31510065 Free PMC article.
-
Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives.Int J Mol Sci. 2024 Feb 28;25(5):2798. doi: 10.3390/ijms25052798. Int J Mol Sci. 2024. PMID: 38474047 Free PMC article. Review.
Cited by
-
Proteomic Alterations in Salivary Exosomes Derived from Human Papillomavirus-Driven Oropharyngeal Cancer.Mol Diagn Ther. 2021 Jul;25(4):505-515. doi: 10.1007/s40291-021-00538-2. Epub 2021 Jun 2. Mol Diagn Ther. 2021. PMID: 34080172
-
Emerging Trends in the Pathological Research of Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma.J Clin Transl Pathol. 2022;2(2):31-36. doi: 10.14218/jctp.2022.00004. Epub 2022 Apr 1. J Clin Transl Pathol. 2022. PMID: 36275841 Free PMC article.
-
Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.J Clin Invest. 2021 Jan 19;131(2):e137001. doi: 10.1172/JCI137001. J Clin Invest. 2021. PMID: 33232304 Free PMC article.
-
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer.Cancer Immunol Res. 2023 Mar 1;11(3):306-319. doi: 10.1158/2326-6066.CIR-22-0454. Cancer Immunol Res. 2023. PMID: 36633583 Free PMC article.
-
Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma.Cancers (Basel). 2022 Aug 27;14(17):4151. doi: 10.3390/cancers14174151. Cancers (Basel). 2022. PMID: 36077689 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical